Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:12-13 (7 July), doi:10.1136/bmj.39262.516806.DB
Bob Burton
Canberra
| The first 150 words of the full text of this article appear below. |
A court ruling has upheld the validity of a requirement that member companies of Australia's leading lobby group for the drug industry disclose details of hospitality provided at "educational" events for doctors.
In July 2006 the Australian Competition and Consumer Commission approved a revised self regulatory code of conduct developed by Medicines Australia, with the proviso that member companies submit details of hospitality provided and that the data be made publicly available on the group's website (BMJ 2006;333:278, doi: 10.1136/bmj.333.7562.278-b).
Subsequently, Medicines Australia lodged an appeal with the Australian Competition Tribunal, disputing that the additional requirements would be of public benefit and proposing that the code be approved for five years rather than three.
In its judgment, the tribunal noted that the code of conduct monitoring committee, which reviewed materials for more than 4700 events held between 2003 and 2005, lacked rigour. "Given the volume of events and
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses